NCT00336934View on ClinicalTrials.gov

Pomegranate Extract in Treating Patients With Rising Prostate-Specific Antigen Levels After Surgery or Radiation Therapy for Localized Prostate Cancer

NACompletedINTERVENTIONAL

Enrollment

183

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

July 31, 2010

Study Completion Date

December 31, 2010

Conditions

Prostate Cancer

Interventions

DIETARY_SUPPLEMENT

pomegranate juice

Given orally daily.

OTHER

placebo

Given orally daily.

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Roll International Corporation

INDUSTRY

NCT00336934 - Pomegranate Extract in Treating Patients With Rising Prostate-Specific Antigen Levels After Surgery or Radiation Therapy for Localized Prostate Cancer | Biotech Hunter | Biotech Hunter